Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Long-Term Efficacy of First-Line Ibrutinib Treatment for Chronic Lymphocytic Leukemia (CLL) With 4 Years of Follow-Up in Patients With TP53 Aberrations (del(17p) or TP53 Mutation): A Pooled Analysis From 4 Clinical Trials

John N. Allan, MD, Tait Shanafelt, MD, Adrian Wiestner, MD PhD, Carol Moreno, MD PhD, Susan M. O'Brien, MD, Esteban Braggio, PhD, Emily Liu, MS, James P. Dean, MD PhD, Dominic Lai, PharmD, Inhye E. Ahn, MD

Blood (2020) 136 (Supplement 1): 23–24.

https://doi.org/10.1182/blood-2020-134431

Published: 2020

Journal Articles

Polygenic Risk Score and Risk of Chronic Lymphocytic Leukemia, Monoclonal B-Cell Lymphocytosis (MBL), and MBL Subtypes

Geffen Kleinstern, PhD, J. Brice Weinberg, MD, Sameer A. Parikh, MD, Esteban Braggio, PhD, Dennis P. Robinson, Aaron D. Norman, MPH, Kari G Rabe, Celine M. Vachon, PhD, Connie E. Lesnick, Timothy G. Call, MD, Danielle M. Brander, MD, Janet E. Olson, PhD, James R. Cerhan, MD PhD, Neil E. Kay, MD, Curtis A. Hanson, MD, Richard R. Furman, MD, Tait Shanafelt, MD, Susan L. Slager, PhD

Blood (2020) 136 (Supplement 1): 35–36.

https://doi.org/10.1182/blood-2020-136548

Published: 2020

Journal Articles

Clinical Characteristics and Outcomes of Newly Diagnosed Patients with Chronic Lymphocytic Leukemia Who Are 80 Years of Age or Older

Paul J. Hampel, MD, Timothy G. Call, MD, Kari G Rabe, Sara J. Achenbach, Eli Muchtar, MD, Saad S. Kenderian, MB, ChB, Yucai Wang, MDPhD, Amber B. Koehler, PA-C, MS, Jose F. Leis, MD PhD, Susan M. Schwager, Daniel L. Van Dyke, PhD, Min Shi, MDPhD, Curtis A. Hanson, MD, Tait Shanafelt, MD, Esteban Braggio, PhD, Susan L. Slager, PhD, Neil E. Kay, MD, Wei Ding, MD PhD, Sameer A. Parikh, MD

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-137578

Published: 2020

Journal Articles

Vitamin D Insufficiency and Prognosis In Chronic Lymphocytic Leukemia (CLL)

Tait Shanafelt, MD, Matthew Drake, Matthew Mauer, Cristine Allmer, Kari Rabe, Susan Slager, PhD, George Weiner, MD, Timothy Call, MD, Brian Link, Clive S. Zent, MD, Neil E. Kay, Curtis Hanson, Thomas E. Witzig, MD, James Cerhan, MD, PhD

Blood (2010) 116 (21): 2408.

https://doi.org/10.1182/blood.V116.21.2408.2408

Published: 2010

Journal Articles

Monoclonal and Polyclonal Serum Free Light Chains and Clinical Outcome In Chronic Lymphocytic Leukemia

Matthew J Maurer, James Cerhan, MD, PhD, Jerry A Katzmann, PhD, Brian Link, Cristine Allmer, Clive S. Zent, MD, Timothy Call, MD, Kari Rabe, Curtis A. Hanson, MD, Neil E. Kay, Susan Slager, PhD, Thomas E. Witzig, MD, Tait Shanafelt, MD

Blood (2010) 116 (21): 2409.

https://doi.org/10.1182/blood.V116.21.2409.2409

Published: 2010

Journal Articles

Lendalidomide Consolidation After First-Line Chemoimmunotherapy for Patients with Previously Untreated CLL

Tait Shanafelt, MD, Han Tun, MD, Curtis Hanson, Clive S. Zent, MD, Jose Leis, Timothy Call, MD, Betsy LaPlant, Deborah Bowen, Kristina Laumann, Diane F. Jelinek, PhD, Neil E. Kay

Blood (2010) 116 (21): 1379.

https://doi.org/10.1182/blood.V116.21.1379.1379

Published: 2010

Journal Articles

A Novel Receptor Tyrosine Kinase Axl is Constitutively Active in B-Cell Chronic Lymphocytic Leukemia and Acts as a Docking Site of Non-Receptor Kinases: Implications for Therapy

Asish K Ghosh, PhD, Charla Secreto, Justin Boysen, Traci Sassoon, Sacha Holland, Tait Shanafelt, MD, Debabrata Mukhopadhyay, Neil E. Kay

Blood (2010) 116 (21): 54.

https://doi.org/10.1182/blood.V116.21.54.54

Published: 2010

Journal Articles

Infectious Complications In a Prospective Cohort of Community Based Newly Diagnosed Patients with Chronic Lymphocytic Leukemia (CLL).

Jonathan Moreira, MD, Timothy Call, MD, Kari Rabe, Randy Wendt, Clive S. Zent, MD, Neil E. Kay, MD, Deborah Bowen, Jose Leis, MD, Susan Slager, PhD, Jon Wilson, MD, Tait Shanafelt, MD

Blood (2010) 116 (21): 4610.

https://doi.org/10.1182/blood.V116.21.4610.4610

Published: 2010

Journal Articles

Longitudinal Genomic Analyses In Chronic Lymphocytic Leukemia (CLL) Patients Reveal Clonal Relationship and Genomic Evolution In Disease Progression and After Therapy

Esteban Braggio, Neil E. Kay, Scott Van Wier, Stephanie Smoley, Jeanette Eckel-Passow, Traci Sassoon, Daniel L. Van Dyke, PhD, Diane F. Jelinek, PhD, Tait Shanafelt, MD, Renee Tschumper, Mike Barrett, Thomas J. Kipps, MD, PhD, John C. Byrd, MD, Rafael Fonseca

Blood (2010) 116 (21): 3605.

https://doi.org/10.1182/blood.V116.21.3605.3605

Published: 2010

Journal Articles

Stromal Rescue of Drug Exposed CLL Cells Can Be Overcome by the Green Tea Extract Epigallocatechin 3 Gallate

Connie 1Lesnick, Neil E. Kay, Betsy LaPlant, Tait Shanafelt, MD

Blood (2010) 116 (21): 3610.

https://doi.org/10.1182/blood.V116.21.3610.3610

Published: 2010

Journal Articles

Survival of Patients with Clinically Identified Monoclonal B-Cell Lymphocytosis (MBL) Relative to the Age and Sex Matched General Population

Tait Shanafelt, MD, Neil E. Kay, Kari Rabe, Timothy Call, MD, Clive S. Zent, MD, Susan Schwager, Jose Leis, Diane F. Jelinek, PhD, Susan Slager, PhD, Curtis Hanson

Blood (2010) 116 (21): 700.

https://doi.org/10.1182/blood.V116.21.700.700

Published: 2010

Journal Articles

Aberrant Regulation of pVHL Levels by Microrna May Explain Autocrine Secretion of VEGF in CLL B Cells.

Asish K Ghosh, PhD, Tait Shanafelt, MD, George A Calin, MD, PhD, Carlo M. Croce, MD, Linda Wellik, Debabrata Mukhopadhyay, Neil Kay

Blood (2008) 112 (11): 1064.

https://doi.org/10.1182/blood.V112.11.1064.1064

Published: 2008

Journal Articles

B-Cell Count and Survival: Differentiating Chronic Lymphocytic Leukemia (CLL) from and Monoclonal B-Cell Lymphocytosis (MBL) Based on Clinical Outcome.

Tait Shanafelt, MD, Neil E. Kay, Gregory Jenkins, Timothy G. Call, Clive S. Zent, Diane F. Jelinek, Justin Boysen, Susan Schwager, Deborah Bowen, Liam Zakko, Susan L. Slager, Curtis A. Hanson

Blood (2008) 112 (11): 2062.

https://doi.org/10.1182/blood.V112.11.2062.2062

Published: 2008

Journal Articles

Treatment Free Survival of Patients with MBL and Early CLL: Follow-up of 405 Patients at Mayo Clinic.

Tait Shanafelt, MD, Neil E. Kay, Kari Rabe, Timothy G. Call, Clive S. Zent, Kami Maddocks, MD, Diane F. Jelinek, Justin Boysen, Deborah Bowen, Susan Schwager, Gregory Jenkins, Susan L. Slager, PhD, Curtis A. Hanson

Blood (2008) 112 (11): 2063.

https://doi.org/10.1182/blood.V112.11.2063.2063

Published: 2008

Journal Articles

Mcl-1 as a Possible Predictor of Progression-Free Survival in Previously Untreated Chronic Lymphocytic Leukemia Patients Treated with Pentostatin, Cyclophosphamide and Rituximab.

Farrukh Awan, MD, MS, Neil E. Kay, Melanie Davis, Wenting Wu, Nelson Leung, Diane F. Jelinek, Renee Tschumper, Charla Secreto, Thomas S. Lin, Michael R Grever, MD, Tait Shanafelt, MD, Clive S. Zent, Timothy G. Call, Nyla A. Heerema, PhD, Gerard Lozanski, John C. Byrd, MD, David Lucas, PhD

Blood (2008) 112 (11): 2105.

https://doi.org/10.1182/blood.V112.11.2105.2105

Published: 2008

Journal Articles

A Phase I Trial of CpG-7909, Rituximab Immunotherapy, and Y90 Zevalin Radioimmunotherapy for Patients (Pts) with Previously Treated CD20+ Non-Hodgkin Lymphoma (NHL).

Thomas E. Witzig, MD, Gregory A. Wiseman, MD, George Weiner, MD, Stephen M. Ansell, MD, PHD, Ivana Micallef, MD, Thomas M. Habermann, MD, Clive S. Zent, MD, David J. Inwards, MD, Tait Shanafelt, MD, Luis Porrata, MD, Matthew J. Maurer, MS, Cristine Allmer, Zuhair Ballas, MD

Blood (2007) 110 (11): 124.

https://doi.org/10.1182/blood.V110.11.124.124

Published: 2007

Journal Articles

Elevated HIF-1α Levels in CLL B Cells May Explain Their Autocrine VEGF Secretion.

Yean K. Lee, Tait Shanafelt, MD, Denise Chan, Amato Giaccia, Debabrata Mukhopadhyay, PhD, Cristian Taccioli, George Calin, Carlo Croce, MD, Neil E. Kay, MD

Blood (2006) 108 (11): 583.

https://doi.org/10.1182/blood.V108.11.583.583

Published: 2006

Journal Articles

Combination Chemoimmunotherapy with Pentostatin, Cyclophosphamide and Rituximab Shows Significant Clinical Activity with Low Accompanying Toxicity in Previously Untreated B-Chronic Lymphocytic Leukemia.

Neil Kay, MD, Susan Geyer, PhD, Timothy Call, MD, Tait Shanafelt, MD, Clive Zent, MD, Diane Jelinek, PhD, Renee Tschumper, Nancy Bone, Gordon Dewald, PhD, Thomas Lin, PhD, Nyla Heerema, PhD, Laura Smith, Michael Grever, MD, John Byrd, MD

Blood (2006) 108 (11): 35.

https://doi.org/10.1182/blood.V108.11.35.35

Published: 2006

Journal Articles

Submicroscopic Interstitial Deletions in 13q14 Are Detectable in Metaphase Cells by Fluorescence In Situ Hybridization (FISH) with D13S319 in Chronic Lymphocytic Leukemia (B-CLL).

Daniel L. Van Dyke, PhD, Kimberly Stockero, Stephanie Fink, Stephanie Smoley, Sarah Paternoster, Susan Schwager, Tait Shanafelt, MD, Clive Zent, MD, Timothy Call, MD, Neil Kay, MD, Gordon Dewald, PhD

Blood (2005) 106 (11): 3278.

https://doi.org/10.1182/blood.V106.11.3278.3278

Published: 2005

Journal Articles

Loss of p53 Is Due to Rearrangements in a ~6,400 kb Region of Low Copy Repeats near the Centromere of Chromosome 17 in Chronic Lymphocytic Leukemia (B-CLL).

Gordon W. Dewald, PhD, Stephanie Fink, Stephanie Smoley, Kimberly Stockero, Sarah Paternoster, Schwager Susan, Erik C. Thorland, PhD, Daniel L. Van Dyke, PhD, Tait Shanafelt, MD, Clive Zent, MD, Timothy Call, MD, Neil Kay, MD

Blood (2005) 106 (11): 3255.

https://doi.org/10.1182/blood.V106.11.3255.3255

Published: 2005

NARROW

Long-Term Efficacy of First-Line Ibrutinib Treatment for Chronic Lymphocytic Leukemia (CLL) With 4 Years of Follow-Up in Patients With TP53 Aberrations (del(17p) or TP53 Mutation): A Pooled Analysis From 4 Clinical Trials

Polygenic Risk Score and Risk of Chronic Lymphocytic Leukemia, Monoclonal B-Cell Lymphocytosis (MBL), and MBL Subtypes

Clinical Characteristics and Outcomes of Newly Diagnosed Patients with Chronic Lymphocytic Leukemia Who Are 80 Years of Age or Older

Vitamin D Insufficiency and Prognosis In Chronic Lymphocytic Leukemia (CLL)

Monoclonal and Polyclonal Serum Free Light Chains and Clinical Outcome In Chronic Lymphocytic Leukemia

Lendalidomide Consolidation After First-Line Chemoimmunotherapy for Patients with Previously Untreated CLL

A Novel Receptor Tyrosine Kinase Axl is Constitutively Active in B-Cell Chronic Lymphocytic Leukemia and Acts as a Docking Site of Non-Receptor Kinases: Implications for Therapy

Infectious Complications In a Prospective Cohort of Community Based Newly Diagnosed Patients with Chronic Lymphocytic Leukemia (CLL).

Longitudinal Genomic Analyses In Chronic Lymphocytic Leukemia (CLL) Patients Reveal Clonal Relationship and Genomic Evolution In Disease Progression and After Therapy

Stromal Rescue of Drug Exposed CLL Cells Can Be Overcome by the Green Tea Extract Epigallocatechin 3 Gallate

Survival of Patients with Clinically Identified Monoclonal B-Cell Lymphocytosis (MBL) Relative to the Age and Sex Matched General Population

Aberrant Regulation of pVHL Levels by Microrna May Explain Autocrine Secretion of VEGF in CLL B Cells.

B-Cell Count and Survival: Differentiating Chronic Lymphocytic Leukemia (CLL) from and Monoclonal B-Cell Lymphocytosis (MBL) Based on Clinical Outcome.

Treatment Free Survival of Patients with MBL and Early CLL: Follow-up of 405 Patients at Mayo Clinic.

Mcl-1 as a Possible Predictor of Progression-Free Survival in Previously Untreated Chronic Lymphocytic Leukemia Patients Treated with Pentostatin, Cyclophosphamide and Rituximab.

A Phase I Trial of CpG-7909, Rituximab Immunotherapy, and Y90 Zevalin Radioimmunotherapy for Patients (Pts) with Previously Treated CD20+ Non-Hodgkin Lymphoma (NHL).

Elevated HIF-1α Levels in CLL B Cells May Explain Their Autocrine VEGF Secretion.

Combination Chemoimmunotherapy with Pentostatin, Cyclophosphamide and Rituximab Shows Significant Clinical Activity with Low Accompanying Toxicity in Previously Untreated B-Chronic Lymphocytic Leukemia.

Submicroscopic Interstitial Deletions in 13q14 Are Detectable in Metaphase Cells by Fluorescence In Situ Hybridization (FISH) with D13S319 in Chronic Lymphocytic Leukemia (B-CLL).

Loss of p53 Is Due to Rearrangements in a ~6,400 kb Region of Low Copy Repeats near the Centromere of Chromosome 17 in Chronic Lymphocytic Leukemia (B-CLL).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only